R Stone. Show Affiliations »
Abstract
Entities: Disease Gene
Mesh: See more » Combined Modality TherapyHumansInterleukin-2/therapeutic useKiller Cells, Lymphokine-Activated/immunologyNeoplasms/drug therapyNeoplasms/therapyUnited StatesUnited States Food and Drug Administration
Substances: See more » Interleukin-2
Year: 1992 PMID: 1736353 DOI: 10.1126/science.1736353
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728